| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Daniel H Sterman | |
| Steven M Albelda | |||
| P2860 | cites work | Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems | Q24679305 |
| Statement on malignant mesothelioma in the United Kingdom | Q30478608 | ||
| Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura--a single-institution experience with 189 patients | Q33177646 | ||
| Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study | Q33348171 | ||
| Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma | Q33362340 | ||
| Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma | Q34107623 | ||
| Incidence of malignant pleural mesothelioma due to environmental asbestos fiber exposure in the southeast of Turkey | Q34109803 | ||
| Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma | Q34214330 | ||
| The role of imaging in malignant pleural mesothelioma. | Q34522988 | ||
| New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents | Q34523037 | ||
| Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma | Q35006946 | ||
| Surgical treatment of malignant pleural mesothelioma: a review | Q35063239 | ||
| Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma | Q35184119 | ||
| The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma | Q35185928 | ||
| Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability | Q35440433 | ||
| Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma. | Q35535634 | ||
| A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma | Q36625951 | ||
| Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study | Q36683621 | ||
| Long-term results of intrathoracic chemohyperthermia (ITCH) for the treatment of pleural malignancies. | Q37340522 | ||
| The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas | Q38474132 | ||
| Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion. | Q39417909 | ||
| Malignant mesothelioma of the pleura | Q39546293 | ||
| Continuing increase in mesothelioma mortality in Britain. | Q40991450 | ||
| Antitumor activity with the HSV-tk-gene-modified cell line PA-1-STK in malignant mesothelioma | Q41017702 | ||
| Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer | Q41331150 | ||
| Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma | Q41745606 | ||
| Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma: dose finding and toxicity results | Q43759974 | ||
| Simian virus (SV) 40 like sequences in cell lines and tumour biopsies from Australian malignant mesotheliomas | Q43871294 | ||
| Replication-restricted vaccinia as a cytokine gene therapy vector in cancer: persistent transgene expression despite antibody generation. | Q44444702 | ||
| Adenovirus-mediated Bak gene transfer induces apoptosis in mesothelioma cell lines | Q45873629 | ||
| A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesothelioma. | Q45875205 | ||
| Using Gene Expression Ratios to Predict Outcome Among Patients With Mesothelioma | Q47971165 | ||
| Malignant mesothelioma due to environmental exposure to asbestos: follow-up of a Turkish cohort living in a rural area. | Q50711762 | ||
| Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. | Q51687498 | ||
| Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. | Q53341193 | ||
| Immunocytochemical characterization of cell lines from human malignant mesothelioma: characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies. | Q53474007 | ||
| The value of immunohistochemistry of pleural biopsy specimens in the differential diagnosis between malignant mesothelioma and metastatic carcinoma. | Q54192586 | ||
| Mesothelin-family proteins and diagnosis of mesothelioma | Q57297479 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 266-283 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Respirology | Q15753093 |
| P1476 | title | Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma | |
| P478 | volume | 10 |
| Q51373042 | A pilot study of volumetric-modulated arc therapy for malignant pleural mesothelioma. |
| Q33923147 | A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma |
| Q36372618 | A year in review: Respirology 2005 - clinical science |
| Q47912434 | Advances in systemic therapy for malignant mesothelioma: future perspectives |
| Q36743579 | Asbestos Induces Oxidative Stress and Activation of Nrf2 Signaling in Murine Macrophages: Chemopreventive Role of the Synthetic Lignan Secoisolariciresinol Diglucoside (LGM2605). |
| Q28082088 | Bioanalytical techniques for detecting biomarkers of response to human asbestos exposure |
| Q40314573 | Blockade of TNF-alpha decreases both inflammation and efficacy of intrapulmonary Ad.IFNbeta immunotherapy in an orthotopic model of bronchogenic lung cancer |
| Q33243641 | Characterization of human malignant mesothelioma cell lines orthotopically implanted in the pleural cavity of immunodeficient mice for their ability to grow and form metastasis |
| Q28391214 | DNA methylation profile of 28 potential marker loci in malignant mesothelioma |
| Q37142251 | Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis |
| Q36286635 | Differential p16/INK4A cyclin-dependent kinase inhibitor expression correlates with chemotherapy efficacy in a cohort of 88 malignant pleural mesothelioma patients |
| Q80159047 | Endoscopic ultrasound-guided fine needle aspiration is useful for nodal staging in patients with pleural mesothelioma |
| Q33691838 | Evaluation of an attenuated vesicular stomatitis virus vector expressing interferon-beta for use in malignant pleural mesothelioma: heterogeneity in interferon responsiveness defines potential efficacy |
| Q39796367 | Expression of IFN-beta enhances both efficacy and safety of oncolytic vesicular stomatitis virus for therapy of mesothelioma |
| Q36378886 | Gene therapy for malignant mesothelioma: beyond the infant years |
| Q28535472 | Hyaluronan and N-ERC/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesothelioma |
| Q57713501 | Immunohistochemical expression and distribution of VEGFR-3 in malignant mesothelioma |
| Q28390399 | Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients |
| Q28385656 | Increased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapy |
| Q35598236 | Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy |
| Q90383249 | Intramedullary Metastasis to the Cervical Spinal Cord from Malignant Pleural Mesothelioma: Review of the Literature and Case Reports |
| Q35843858 | Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy |
| Q36741786 | Malignant Peritoneum Mesothelioma with Hepatic Involvement: A Single Institution Experience in 5 Patients and Review of the Literature |
| Q87322726 | Malignant mesothelioma |
| Q33871712 | Malignant peritoneal mesothelioma - a rare cause of laparotomy |
| Q36649268 | Malignant peritoneal mesothelioma as a rare cause of ascites: a case report |
| Q37677243 | Malignant peritoneal mesothelioma: clinicopathological characteristics of two cases |
| Q36728254 | Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies. |
| Q36623128 | Molecular tumor markers for asbestos-related mesothelioma: serum diagnostic markers |
| Q24243222 | Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma |
| Q52672900 | Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma. |
| Q37623620 | Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma |
| Q91949964 | Relations between approved platinum drugs and non-coding RNAs in mesothelioma |
| Q35768107 | Surgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesothelioma |
| Q52689052 | Synthetic Lignan Secoisolariciresinol Diglucoside (LGM2605) Reduces Asbestos-Induced Cytotoxicity in an Nrf2-Dependent and -Independent Manner. |
| Q64101494 | Therapeutic efficacy evaluation of radioimmunotherapy with Y-labeled anti-podoplanin antibody NZ-12 for mesothelioma |
| Q87695929 | Turkey Asbestos Control Strategic Plan Final Report |
| Q47151714 | Turkey National Mesothelioma Surveillance and Environmental Asbestos Exposure Control Program. |
| Q64117141 | Versican modulates tumor-associated macrophage properties to stimulate mesothelioma growth |
| Q42157100 | Vesicular stomatitis virus-induced immune suppressor cells generate antagonism between intratumoral oncolytic virus and cyclophosphamide |
Search more.